Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE DATED MARCH 31, 2014. - OxySure Therapeutics, Inc. | f8k033114ex99i_oxysure.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report March 31, 2014
|
OxySure Systems, Inc.
|
|
(Exact name of registrant as specified in its charter)
|
|
Delaware
|
000-54137
|
71-0960725
|
||
|
(State or other jurisdiction of
incorporation
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
10880 John W. Elliott Drive, Suite 600,
Frisco, TX
|
75033
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(972) 294-6450
|
|
Registrant's telephone number, including area code
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events.
On March 31, 2014, OxySure Systems, Inc. (the “Company”) issued a press release in which the Company discloses that its annual filing on form 10-K will be delayed as further explained in the press release, a copy of which is furnished herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
Exhibit 99.1. Press release dated March 31, 2014.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: March 31, 2014
|
||
|
OXYSURE SYSTEMS, INC.,
|
||
|
a Delaware corporation
|
||
|
By:
|
/s/ Julian T. Ross
|
|
|
Julian T. Ross
|
||
|
ITS:
|
Chief Executive Officer, President
|
|
|
Chief Financial Officer, and Secretary
|
||